Page last updated: 2024-09-02

kt 5823 and tafluprost

kt 5823 has been researched along with tafluprost in 1 studies

Compound Research Comparison

Studies
(kt 5823)
Trials
(kt 5823)
Recent Studies (post-2010)
(kt 5823)
Studies
(tafluprost)
Trials
(tafluprost)
Recent Studies (post-2010) (tafluprost)
31705915135113

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukuda, M; Kanamori, A; Naka, M; Nakamura, M; Negi, A1

Other Studies

1 other study(ies) available for kt 5823 and tafluprost

ArticleYear
Tafluprost protects rat retinal ganglion cells from apoptosis in vitro and in vivo.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2009, Volume: 247, Issue:10

    Topics: Animals; Apoptosis; Calcium; Calcium Channel Blockers; Carbazoles; Caspase 3; Cell Line; Cell Survival; Culture Media, Serum-Free; Cyclic GMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Glutamic Acid; In Vitro Techniques; Instillation, Drug; Intracellular Membranes; Intraocular Pressure; Male; Nerve Crush; Neuroprotective Agents; Ophthalmic Solutions; Optic Nerve; Prostaglandins F; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Retinal Ganglion Cells; Time Factors

2009